Jacobson AF, Senior R, Cerqueira MD, et al. ADMIRE-HF Investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212-21
Verberne HJ, Brewster LM, Somsen GA, et al. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147-59
Nakata T, Nakajima K, Yamashina S, et al. A Meta-analysis study for establishing the prognostic efficacy of assessment of cardiac sympathetic innervation by Iodine-123-metaiodobenzylguanidine imaging in chronic heart failure. J Am Coll Cardiol 2012; 59; E1172. American College of Cardiology 61st Annual Scientific Session, March 24-27, 2012, in Chicago, IL, USA.
Nakajima K, Nakata T, Matsuo S, et al. I-123 MIBG meta analysis for predicting cardiac death in heart failure: A multi-center investigation in Japan. J Nucl Med 2012; 53 (Suppl 1): 26P. SNM 2012 Annual Meeting, June 9-13, Miami Beach FL, USA